CorePharma, LLC.

CorePharma, LLC. Contract Manufacturing & Development (CDMO) Profile

CorePharma is a “Quality Driven + People Powered” US based contract development and manufacturing organization (CDMO) of high-quality pharmaceuticals across various therapeutic categories. Our focus is on providing end to end solutions from early-stage drug development through commercial launch and beyond. With an excellent regulatory inspection track record, CorePharma currently operates 5 state-of-the-art, US FDA and DEA registered, development, analytical, clinical and commercial manufacturing and packaging facilities totaling 100,000 sqft and an annual capacity to produce 4 billion dosage units per year. With industry leading lead times, we can truly accelerate your timelines to get your project from the lab to the clinic to the patient.

At CorePharma, we are committed to being your concept to commercial CDMO platform for success.

CDMO Services:
Small Molecule Drug Product Formulation (FDF); Research & Development; Clinical Trials materials and logistics; Packaging; Regulatory Services; Analytical Development Liquids; Solids Analytical Development; Formulation Development; ICH Stability Testing; Process Development

Year Founded: 1998

Head Office: Middlesex, United States

Number of Facilities: 3-5

Facility locations: North America

Website: Visit the CorePharma, LLC. website

Linkedin: Connect on Linkedin

Current Capacity: Our current annual capacity is 4 billion units annually and we are utilizing about 2.5 million units of that. Plenty of room for growth!